Premium Rx Nationalcs@prnpharma.com | (877) 862-7796
Premium Rx National logoPremium Rx National

Sanofi Pasteur Inc.

37 active products from this manufacturer.

Compare NDC listings and package configurations, then submit RFQ requests for facility procurement review.

Need a Product Not Listed?

Submit a custom quote request for unlisted NDCs, item codes, or alternate product presentations.

Request a Custom Quote

Drug Catalog Search | Request a Custom Quote

Manufacturer scope

This manufacturer hub consolidates exact-item pages from Sanofi Pasteur Inc.so healthcare teams can review the catalog footprint before narrowing into the exact NDC presentation they need.

  • Indexed footprint: 37 active products.
  • Common generics: CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP, CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen.
  • Dosage forms shown: Injection and Kit.
  • Product-NDC families: 49281-0215, 49281-0400, 49281-0225, and 49281-0286.

How to use this page

Manufacturer hubs help with qualification and sourcing research, but exact-item intent still belongs on the child NDC pages. Use this manufacturer view to identify the right product family, then click into the exact NDC row for package-level details.

Showing page 1 of 1
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL (Tenivac)49281-0215-10CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL (Tenivac)49281-0215-15CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL (Adacel, TDaP)49281-0400-05CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL (Adacel, TDaP)49281-0400-10CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mL Injection 0.5 mL (Adacel, TDaP)49281-0400-20CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), BORDETELLA PERTUSSIS PERTACTIN ANTIGEN, and BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN, TDaP5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 2.5 ug / .5mL; 5 [Lf] / .5mL; 2 [Lf] / .5mLInjection
CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) 5 [Lf] / .5mL; 25 [Lf] / .5mL Injection 0.5 mL (Diphtheria And Tetanus Toxoids Adsorbed)49281-0225-10CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)5 [Lf] / .5mL; 25 [Lf] / .5mLInjection
corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL (Daptacel)49281-0286-01corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mLInjection
corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL (Daptacel)49281-0286-05corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mLInjection
corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen 5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL Injection 0.5 mL (Daptacel)49281-0286-10corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), clostridium tetani toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen5 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 10 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mLInjection
Dengue Tetravalent Vaccine, Live Kit 1 Kit (Dengvaxia)49281-0605-01Dengue Tetravalent Vaccine, Live-Kit
diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine 20 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 20 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL; 29 [D'ag'U] / .5mL; 7 [D'ag'U] / .5mL; 26 [D'ag'U] / .5mL Injection 0.5 mL (Quadracel)49281-0564-10diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine20 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 20 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL; 29 [D'ag'U] / .5mL; 7 [D'ag'U] / .5mL; 26 [D'ag'U] / .5mLInjection
diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine 20 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 20 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL; 29 [D'ag'U] / .5mL; 7 [D'ag'U] / .5mL; 26 [D'ag'U] / .5mL Injection 0.5 mL (Quadracel)49281-0564-15diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine20 ug / .5mL; 5 ug / .5mL; 3 ug / .5mL; 20 ug / .5mL; 5 [Lf] / .5mL; 15 [Lf] / .5mL; 29 [D'ag'U] / .5mL; 7 [D'ag'U] / .5mL; 26 [D'ag'U] / .5mLInjection
Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed, Inactivated Poliovirus And Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine Kit 1 Kit (Pentacel)49281-0511-05Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed, Inactivated Poliovirus And Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine-Kit
INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 0.5 mL (Fluzone Trivalent Northern Hemisphere)49281-0425-50INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mLInjection
INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 5 mL (Fluzone Trivalent Northern Hemisphere)49281-0643-15INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mLInjection
INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug / .5mL; 60 ug / .5mL; 60 ug / .5mL Injection 0.5 mL (Fluzone High Dose Northern Hemisphere)49281-0125-65INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug / .5mL; 60 ug / .5mL; 60 ug / .5mLInjection
INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 0.5 mL (Fluzone Quadrivalent Northern Hemisphere)49281-0926-50INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mLInjection
INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL Injection 0.7 mL (Fluzone High-Dose Quadrivalent Northern Hemisphere)49281-0226-65INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mL; 60 ug / .7mLInjection
INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 5 mL (Fluzone Quadrivalent Northern Hemisphere)49281-0541-15INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136RV/2023 X-425A ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED)15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mLInjection
INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN 45 ug / .5mL; 45 ug / .5mL; 45 ug / .5mL Injection 0.5 mL (Flublok Trivalent Northern Hemisphere)49281-0725-10INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN45 ug / .5mL; 45 ug / .5mL; 45 ug / .5mLInjection
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN 4 ug / .5mL; 4 ug / .5mL; 4 ug / .5mL; 4 ug / .5mL Injection 0.5 mL (Menactra)49281-0589-05NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN4 ug / .5mL; 4 ug / .5mL; 4 ug / .5mL; 4 ug / .5mLInjection
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL (MenQuadfi)49281-0590-01NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mLInjection
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL (MenQuadfi)49281-0590-05NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mLInjection
NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL Injection 0.5 mL (MenQuadfi)49281-0590-10NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, and NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mL; 10 ug / .5mLInjection
nirsevimab 100 mg / mL Injection 0.5 mL (Beyfortus)49281-0575-00nirsevimab100 mg / mLInjection
nirsevimab 100 mg / mL Injection 0.5 mL (Beyfortus)49281-0575-15nirsevimab100 mg / mLInjection
nirsevimab 100 mg / mL Injection 1 mL (Beyfortus)49281-0574-15nirsevimab100 mg / mLInjection
nirsevimab 100 mg / mL Injection 1 mL (Beyfortus)49281-0574-88nirsevimab100 mg / mLInjection
POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) 40 [D'ag'U] / .5mL; 8 [D'ag'U] / .5mL; 32 [D'ag'U] / .5mL Injection 5 mL (Ipol)49281-0860-10POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)40 [D'ag'U] / .5mL; 8 [D'ag'U] / .5mL; 32 [D'ag'U] / .5mLInjection
Salmonella Typhi Ty2 Vi Polysaccharide Antigen 25 ug / .5mL Injection 0.5 mL (Typhim Vi)49281-0790-51Salmonella Typhi Ty2 Vi Polysaccharide Antigen25 ug / .5mLInjection
Salmonella Typhi Ty2 Vi Polysaccharide Antigen 25 ug / .5mL Injection 10 mL (Typhim Vi)49281-0790-20Salmonella Typhi Ty2 Vi Polysaccharide Antigen25 ug / .5mLInjection
Sodium Chloride 4.5 mg / .5mL Injection 0.6 mL (Diluent)49281-0912-05Sodium Chloride4.5 mg / .5mLInjection
Sodium Chloride 4.5 mg / .5mL Injection 3 mL (Diluent)49281-0912-10Sodium Chloride4.5 mg / .5mLInjection
Tuberculin Purified Protein Derivative 5 [iU] / .1mL Injection 1 mL (Tubersol)
View in Drug Shortage Index
49281-0752-21Tuberculin Purified Protein Derivative5 [iU] / .1mLInjection
Tuberculin Purified Protein Derivative 5 [iU] / .1mL Injection 5 mL (Tubersol)
View in Drug Shortage Index
49281-0752-22Tuberculin Purified Protein Derivative5 [iU] / .1mLInjection
Yellow Fever Virus Strain 17D-204 Live Antigen 4.74 [PFU] / .5mL Injection 0.5 mL (Yf-Vax)49281-0915-01Yellow Fever Virus Strain 17D-204 Live Antigen4.74 [PFU] / .5mLInjection
Yellow Fever Virus Strain 17D-204 Live Antigen 4.74 [PFU] / .5mL Injection 2.5 mL (Yf-Vax)49281-0915-05Yellow Fever Virus Strain 17D-204 Live Antigen4.74 [PFU] / .5mLInjection

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.